Prescient Therapeutics in the burgeoning field of precision cancer medicines | No.1
August 7, 2019
This investor centre was built by Reach Markets
©2022 Reach Markets
Any advice provided by Reach Markets, the Lead Manager on this offer, including on its website and by its representatives is general advice only and does not consider your objectives, financial situation or needs, and you should consider whether it’s appropriate for you. This might mean that you need to seek personal advice from a representative authorised to provide personal advice.
To stay up to date with Prescient Therapeutics news and events, please register your details.
By submitting this form, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement. Reach provides Corporate Advisory Services, including managing investor communications on behalf of Prescient Therapeutics Limited and may receive fees for its services.